Allarity Therapeutics Inc... (ALLR)
NASDAQ: ALLR
· Real-Time Price · USD
0.95
-0.03 (-3.04%)
At close: Aug 15, 2025, 3:59 PM
0.99
3.97%
After-hours: Aug 15, 2025, 07:15 PM EDT
Allarity Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -23.4M | -24.52M | -18.78M | -11.64M | -12.39M | -11.9M | -13.02M | -13.61M | -15.88M | -15.61M | -33.44M | -25.9M | -26.64M | -26.65M | -6.11M | -9.95M | -5.06M |
Depreciation & Amortization | 18K | 9K | 17K | 21K | 29K | 37K | 30K | 32K | 47K | 60K | 74K | 100K | 73K | 106K | 26K | 30.41K | 73.96K |
Stock-Based Compensation | 331K | 71K | -247K | -140K | -71K | -71K | 523K | 805K | 566K | 1.75M | 6.58M | 6.75M | 7.24M | 6.37M | 1.19M | 740.23K | 458.29K |
Other Working Capital | 3.49M | 4.05M | 1.21M | 1.24M | 632K | -132K | -1.59M | -222K | 541K | -6.81M | 636K | 189K | -260K | 6.88M | 12K | -655.12K | -1.82M |
Other Non-Cash Items | 7.87M | 5.03M | 1.47M | -7.48M | -4.87M | -2.34M | 333K | -698K | -981K | -694K | 2.88M | -1.67M | -1.02M | -466K | -4.32M | -203.49K | -559.27K |
Deferred Income Tax | -432K | -446K | -349K | 73K | -1.84M | -1.83M | -2.19M | -2.3M | -385K | -1.61M | -847K | -1.18M | -1.24M | 20K | -1.94M | -1.49M | -1.44M |
Change in Working Capital | -2.83M | 63K | -365K | 975K | 5.67M | 3.35M | 805K | 3.22M | 2.48M | -604K | 5.18M | 3.83M | 3.36M | 5.57M | -1.03M | -99.12K | -1.38M |
Operating Cash Flow | -18.55M | -17.35M | -15.82M | -15.75M | -11.03M | -12.74M | -13.52M | -12.55M | -13.96M | -16.52M | -19.38M | -17.88M | -18.24M | -15.05M | -12.18M | -10.97M | -7.9M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -18K | -18K | -18K | -18K | n/a | n/a | n/a | n/a | n/a | -2.99K | -2.99K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -298K | -298K | 116K | 116K | 116K | 116K | -18K | -18K | -18K | 791K | 806K | 1.81M | 1.81M | 997K | 997K | -3K | -3K |
Investing Cash Flow | -298K | -298K | 116K | 116K | n/a | n/a | -134K | -134K | -18K | 791K | 806K | 1.81M | 1.81M | 997K | 997K | -5.99K | -5.99K |
Debt Repayment | -1.34M | n/a | -1.72M | -351K | -1.31M | -2.65M | 72K | -1.3M | 1M | 1M | -157K | -61K | -1.35M | 970K | 3.1M | 2.98M | 4.25M |
Common Stock Repurchased | n/a | n/a | 6.65M | 1.65M | 2K | n/a | -6.65M | -1.65M | -1.51M | -1.51M | -1.51M | -1.51M | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | -228K | -228K | -228K | -228K | n/a | -1.57M | -1.57M | -1.57M | -3.14M | -1.57M | -1.57M | -1.57M | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 2.24M | 2.24M | 2.24M | 2.24M | 1.57M | 1.57M | 772K | 772K | 544K | 2K | 12.81M | 12.81M | 11.39M | 13.25M | 2.84M |
Financial Cash Flow | 46.55M | 36.79M | 33.08M | 34.66M | 11.22M | 10.99M | 11.47M | 5.02M | -153K | -2.88M | 14.55M | 16.9M | 29.92M | 33.82M | 18.08M | 17.02M | 7.89M |
Net Cash Flow | 27.39M | 19.37M | 17.06M | 18.81M | 17K | -1.86M | -2.55M | -7.26M | -14.29M | -17.56M | -1.68M | 1.04M | 14.44M | 19.26M | 5.55M | 6.21M | 104.04K |
Free Cash Flow | -18.85M | -17.65M | -15.82M | -15.75M | -11.03M | -12.74M | -13.54M | -12.57M | -13.98M | -16.54M | -19.38M | -17.88M | -18.24M | -15.05M | -12.18M | -10.97M | -7.9M |